1. Home
  2. OCS vs GSL Comparison

OCS vs GSL Comparison

Compare OCS & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • GSL
  • Stock Information
  • Founded
  • OCS 2003
  • GSL 2007
  • Country
  • OCS Switzerland
  • GSL Greece
  • Employees
  • OCS N/A
  • GSL N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • GSL Marine Transportation
  • Sector
  • OCS Health Care
  • GSL Consumer Discretionary
  • Exchange
  • OCS Nasdaq
  • GSL Nasdaq
  • Market Cap
  • OCS 689.8M
  • GSL 758.7M
  • IPO Year
  • OCS N/A
  • GSL 2006
  • Fundamental
  • Price
  • OCS $18.58
  • GSL $22.09
  • Analyst Decision
  • OCS Strong Buy
  • GSL Strong Buy
  • Analyst Count
  • OCS 4
  • GSL 1
  • Target Price
  • OCS $31.50
  • GSL $29.00
  • AVG Volume (30 Days)
  • OCS 30.4K
  • GSL 266.8K
  • Earning Date
  • OCS 05-08-2025
  • GSL 05-19-2025
  • Dividend Yield
  • OCS N/A
  • GSL 8.16%
  • EPS Growth
  • OCS N/A
  • GSL 17.78
  • EPS
  • OCS N/A
  • GSL 9.67
  • Revenue
  • OCS $847,333.00
  • GSL $705,529,000.00
  • Revenue This Year
  • OCS $49.27
  • GSL $1.84
  • Revenue Next Year
  • OCS $1,920.31
  • GSL N/A
  • P/E Ratio
  • OCS N/A
  • GSL $2.28
  • Revenue Growth
  • OCS N/A
  • GSL 5.82
  • 52 Week Low
  • OCS $10.79
  • GSL $17.73
  • 52 Week High
  • OCS $23.08
  • GSL $30.32
  • Technical
  • Relative Strength Index (RSI)
  • OCS 54.68
  • GSL 58.00
  • Support Level
  • OCS $18.01
  • GSL $21.26
  • Resistance Level
  • OCS $19.50
  • GSL $22.23
  • Average True Range (ATR)
  • OCS 0.77
  • GSL 0.49
  • MACD
  • OCS 0.17
  • GSL 0.18
  • Stochastic Oscillator
  • OCS 66.30
  • GSL 94.31

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About GSL Global Ship Lease Inc New

Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.

Share on Social Networks: